| Alembic Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 533573 |
NSE Symbol : APLLTD |
P/E(TTM) : 20.33 |
|
ISIN Demat : INE901L01018 |
Div & Yield% : 1.47 |
EPS(TTM) : 40.14 |
|
Book Value(₹) : 285.67 |
Market Cap(₹Cr) : 16,041.52 |
Face Value(₹) : 2.00 |
| Particulars | Dec '26 | Dec '25 | Dec '24 | Dec '23 | Dec '22 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 6,651.38 | 6,032.63 | 5,874.06 | 5,149.00 | 5,035.41 |
| Other Income | 55.90 | 60.75 | 504.88 | 3.55 | 51.14 |
| Stock Adjustments | 121.15 | 268.54 | 52.36 | -72.84 | -19.85 |
| Total Income | 6,828.43 | 6,361.92 | 6,431.30 | 5,079.71 | 5,066.70 |
| EXPENDITURE : | |||||
| Raw Materials | 2,141.95 | 2,057.31 | 1,852.71 | 1,587.29 | 1,482.36 |
| Power and Fuel Cost | 177.44 | 179.67 | 173.32 | 151.19 | 120.50 |
| Other Manufacturing Expenses | 434.18 | 388.12 | 327.87 | 357.21 | 324.10 |
| Selling and Administration Expenses | 1,299.56 | 1,269.90 | 1,191.89 | 1,173.00 | 1,088.67 |
| Miscellaneous Expenses | 110.78 | 38.21 | 519.76 | 48.32 | 28.82 |
| Employee Benefit Expenses | 1,612.90 | 1,466.57 | 1,335.91 | 1,094.82 | 1,062.30 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 1,051.62 | 962.14 | 1,029.84 | 667.88 | 959.95 |
| Interest | 86.51 | 76.47 | 54.47 | 49.00 | 17.02 |
| Gross Profit | 965.11 | 885.67 | 975.37 | 618.88 | 942.93 |
| Depreciation | 311.00 | 277.08 | 271.14 | 272.95 | 284.92 |
| Profit Before Tax | 654.11 | 608.59 | 704.23 | 345.93 | 658.01 |
| Current Tax | 115.14 | 105.47 | 37.75 | -0.80 | 114.46 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -101.45 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reported Net Profit | 640.42 | 503.12 | 666.48 | 346.73 | 543.55 |
| Extraordinary Items | -56.66 | 20.18 | 0.99 | 0.05 | 2.81 |
| Adjusted Net Profit | 697.08 | 482.94 | 665.49 | 346.68 | 540.74 |
| Adjustment below Net Profit | 0.00 | 0.00 | 3,494.43 | 0.00 | -76.31 |
| Profit/Loss Balance carried down | 4,447.81 | 4,160.91 | 0.00 | 2,632.89 | 2,440.83 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 212.54 | 216.22 | 0.00 | -672.06 | 275.19 |
| P & L Balance carried down | 4,875.69 | 4,447.81 | 4,160.91 | 3,651.68 | 2,632.88 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 600.00 | 550.00 | 550.00 | 400.00 | 500.00 |
| Dividend Per Share(Rs) | 12.00 | 11.00 | 11.00 | 8.00 | 10.00 |
| Earnings Per Share-Unit Curr | 32.58 | 25.60 | 33.91 | 17.64 | 27.65 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 285.69 | 264.30 | 249.75 | 224.59 | 269.16 |
| Book Value(Adj)-Unit Curr | 285.69 | 264.30 | 249.75 | 224.59 | 269.16 |
